Cargando…
Role of Glutaredoxin-1 and Glutathionylation in Cardiovascular Diseases
Cardiovascular diseases are the leading cause of death worldwide, and as rates continue to increase, discovering mechanisms and therapeutic targets become increasingly important. An underlying cause of most cardiovascular diseases is believed to be excess reactive oxygen or nitrogen species. Glutath...
Autores principales: | Burns, Mannix, Rizvi, Syed Husain Mustafa, Tsukahara, Yuko, Pimentel, David R., Luptak, Ivan, Hamburg, Naomi M., Matsui, Reiko, Bachschmid, Markus M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555996/ https://www.ncbi.nlm.nih.gov/pubmed/32948023 http://dx.doi.org/10.3390/ijms21186803 |
Ejemplares similares
-
Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis
por: Tsukahara, Yuko, et al.
Publicado: (2022) -
Protein Glutathionylation and Glutaredoxin: Role in Neurodegenerative Diseases
por: A., Haseena P., et al.
Publicado: (2022) -
The redox mechanism for vascular barrier dysfunction associated with metabolic disorders: Glutathionylation of Rac1 in endothelial cells
por: Han, Jingyan, et al.
Publicado: (2016) -
Temporal Changes in Glutaredoxin 1 and Protein S-Glutathionylation in Allergic Airway Inflammation
por: Maki, Kanako, et al.
Publicado: (2015) -
Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas
por: Anathy, Vikas, et al.
Publicado: (2009)